Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease.

The Korean Journal of Internal Medicine
Chin Kook Rhee, Deog Kyeom Kim

Abstract

Phosphodiesterase-4 inhibitors (PDE4Is) are potent anti-inf lammatory agents and roflumilast has been used to prevent acute exacerbation of chronic obstructive pulmonary disease (COPD). Roflumilast decreases neutrophil migration, restores cystic fibrosis transmembrane conductance regulator activity, and recovers glucocorticoid effects. A forced expiratory volume in 1 second of < 50%, a chronic bronchitis phenotype, high blood eosinophil levels, and a history of hospitalization are biomarkers for predicting responses to roflumilast. Adverse effects are common in clinical practice. An inhaled PDE4I has recently been developed and is under clinical trial. CHF6001 and RPL554 exhibit promise and may be future treatment options for COPD.

References

Sep 3, 1999·American Journal of Respiratory and Critical Care Medicine·S MyouT Matsuda
Sep 4, 2007·Lancet·Leonardo M Fabbri, Klaus F Rabe
Sep 1, 2009·Lancet·Peter M A CalverleyUNKNOWN M2-124 and M2-125 study groups
Mar 2, 2010·The Journal of Steroid Biochemistry and Molecular Biology·Peter J Barnes
May 25, 2012·PloS One·Alvar AgustíUNKNOWN Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators
Oct 11, 2013·American Journal of Respiratory Cell and Molecular Biology·James A LambertSteven M Rowe
Mar 19, 2014·The Journal of Allergy and Clinical Immunology·Javier MilaraJulio Cortijo
Sep 5, 2015·Drugs·Karly P Garnock-Jones
Nov 2, 2015·Respiratory Research·Andreas SchmidMatthias Salathe
Nov 7, 2015·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·S W KimH K Yoon
Jan 23, 2016·International Journal of Chronic Obstructive Pulmonary Disease·Jadwiga A WedzichaKlaus F Rabe
Feb 2, 2017·American Journal of Respiratory and Critical Care Medicine·Alex J MackayJadwiga A Wedzicha
Jul 7, 2017·The European Respiratory Journal·Klaus F RabeLeonardo M Fabbri
Sep 2, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Jeong Uk LimChin Kook Rhee
Sep 7, 2017·The New England Journal of Medicine·Mehmet KesimerRichard C Boucher
Dec 23, 2017·International Journal of Chronic Obstructive Pulmonary Disease·Kyung Hoon KimChin Kook Rhee
Mar 23, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Henrik WatzPeter Ma Calverley
May 16, 2018·American Journal of Respiratory and Critical Care Medicine·Fernando J MartinezStephen I Rennard
Aug 14, 2018·International Journal of Chronic Obstructive Pulmonary Disease·Yong Suk JoChin Kook Rhee
Sep 1, 2018·The European Respiratory Journal·Dave SinghKenneth Newman
Sep 22, 2018·Tuberculosis and Respiratory Diseases·Chin Kook Rhee
Oct 12, 2018·Tuberculosis and Respiratory Diseases·Changhwan KimKwang Ha Yoo
Nov 6, 2018·American Journal of Respiratory Cell and Molecular Biology·Amy E DunneLouise E Donnelly
Jul 6, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Chin Kook RheeUNKNOWN on behalf the COPD Assembly of the APSR
Aug 11, 2019·Respiratory Research·Dave SinghMarie Anna Nandeuil

❮ Previous
Next ❯

Citations

Aug 26, 2021·International Journal of Chronic Obstructive Pulmonary Disease·Clémence MartinNicolas Roche

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.